Jason Morrow, M.D.
Morrow’s life, work to be celebrated at science symposium
A scientific symposium celebrating the life and work of the late Jason Morrow, M.D., will be held Friday, July 31, from 12:45 to 5 p.m. in Langford Auditorium.
Presentations will be given by several colleagues of Morrow, the former chief of the Division of Clinical Pharmacology at Vanderbilt Medical Center who died last year.
Raymond DuBois Jr., M.D., Ph.D., provost and executive vice president of the University of Texas M.D. Anderson Cancer Center in Houston, and former director of the Vanderbilt-Ingram Cancer Center, will discuss prostaglandins and cancer.
Thomas Montine, M.D., Ph.D., director of the Division of Neuropathology at the University of Washington in Seattle and a former Vanderbilt faculty member, will describe “therapeutic targets for cognitive impairment and dementia.”
Jackson Roberts, M.D., the T. Edwin Rogers Professor of Pharmacology at Vanderbilt, will discuss his and Morrow's 1990 discovery of a series of compounds called isoprostanes that enable researchers to measure “oxidative stress.”
Other scheduled presenters include Vanderbilt's Lawrence Marnett, Ph.D., John Oates, M.D., and Dan Roden, M.D.; Ian Blair, Ph.D., from the University of Pennsylvania; and Andrew Dannenberg, M.D., director of the Weill Cornell Cancer Center in New York.
Morrow, who joined the Vanderbilt faculty in 1994, co-authored more than 200 scientific papers and contributed to current understanding of the potential of antioxidant vitamins C and E to protect against heart disease.
An endowed fund, the Jason D. Morrow Fellowship in Clinical Pharmacology, has been established to help support future generations of outstanding post-doctoral fellows in clinical pharmacology.
For more information and for a complete listing of speakers and topics, visit the division's Web site at www.mc.vanderbilt.edu/clinicalpharmacology.